Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Alzheon
111 Speen Street, Suite 306
Framingham, MA 01701
Phone: 508-861-7709
www.alzheon.com

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer's disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer's disease patients and where new insights can be applied. Based on a drug development platform that yields diverse and novel compounds, the company is building a pipeline of innovative drugs to target the underlying pathogenesis of neurodegeneration in order to improve the symptoms and slow the progression of these devastating diseases.

Key Contact
Name
Martin Tolar
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/23/13 undisclosed Seed
04/08/15 $10,000,000 Series A Ally Bridge Group
undisclosed